Serum Institute inks deal to produce US-based biotech firm Novavax’s Covid vaccine

The Serum Institute of India (SII) will buy the vaccine components from Novavax and the two companies will equally split the revenue from the sale of the product, net of agreed costs, Novavax said in a US regulatory filing on Wednesday.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.